Now Feluda to detect Covid cases : Tata Group to launch India's CRISPR Covid Test


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Now Feluda to detect Covid cases : Tata Group to launch India's CRISPR Covid Test
FELUDA is actually an acronym - FNACS9 Editor Linked Uniform Detection Assay (FELUDA) – for an indigenous test for rapid diagnosis of Covid-19.

India’s first COVID-19 detecting paper strip ‘Feluda’ delivers results within minutes! One of the most pertinent questions going on in everyone’s head is if they are infected with Coronavirus but have no symptoms? In a matter of minutes, courtesy writer and film-maker Satyajit Ray’s popular fictional detective, ‘Feluda,’ could now clear all your doubts. The ‘Feluda’ is a paper-based test strip that detects the latest coronavirus in an hour, and can now be the solution to the urgent need for rapid testing in India, a LiveMint report indicates.

A team led by two scientists of Bengali descent, Dr. Souvik Maiti and Dr. Debojyoti Chakraborty, at the Institute of Genomics and Integrative Biology (CSIR-IGIB) of the Council of Science & Industrial Research in New Delhi, have come up with a simple strip-test to tell you if you have COVID-19 in minutes, a New18 report has stated. The study uses the state-of-the-art gene-editing tool-Crispr-Cas9 to target and identifies genomic sequences of the novel coronavirus in suspected individual samples.

The kit is similar to a compact paper-strip test used to confirm pregnancy and is much less complex and needs no specific professional expertise to perform. The team led by Dr Souvik Maiti and Dr Debjyoti Chakraborty is currently testing the package in a patient population for its accuracy and responsiveness and hopes to obtain approval within a week from an Indian Medical Research Council (ICMR) regulatory body.

Unlike the real-time PCR test currently being used for Covid-19 diagnosis in India, which costs about 4500, the paper-strip test costs less than 500. It also does not rely on expensive real-time PCR machines for RNA isolation, DNA conversion, and amplification which are already in limited supply, the News18 report indicated.

Although this method has been tested by scientists in other countries including Stanford University and the Massachusetts Institute of Technology (MIT), it is the first such indigenous test kit to be developed in India based on CRISPR technology.

This testing method can be a boon for India where lockdown is about to end and people will have to come back to work. The ability to know if they have Coronavirus infection or not will help firms and employees in decision making over the resumption of coming to the office for work.

Tags : #FeludaCovidTest #FNACS9EditorLinkedUniformDetectionAssay #StanfordUniversity #MIT #MadeInIndiaCovidTest #LatestCovidNewsUpdateSep21 #LatestCovidTestingNewsUpdateSep21

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026